Skip to main content

Table 2 Frequency of antibiotics and their days of therapy (DOT)

From: Characteristics of patients infected with Clostridioides difficile at a Saudi Tertiary Academic Medical Center and assessment of antibiotic duration

Antibiotic

N (%)

DOT (median [IQR])

All antibiotics

159 (100)

17.5 [12.25–26.5]

Piperacillin/tazobactam

62 (39)

14 [5.75–40.5]

Ceftriaxone

60 (37.7)

14 [5–43.25]

Meropenem

59 (37.1)

14 [7–26]

Ciprofloxacin

50 (31.4)

26 [8.75–56.5]

Cefuroxime

37 (23.3)

14 [7.5–44.5]

Gentamicin

18 (11.3)

18 [5.75–44]

Imipenem/cilastatin

19 (11.9)

11 [4–29]

Ceftazidime

17 (10.7)

14 [4.5–40]

Amoxicillin/clavulanic acid

15 (9.4)

10 [9–26]

Clarithromycin

14 (8.8)

11.5 [7.75–34.5]

Clindamycin

14 (8.8)

27 [9.75–58]

Trimethoprim/sulfamethoxazole

12 (7.5)

9.5 [4.25–62.25]

Cefazolin

12 (7.5)

13 [7.5–16.25]

Cloxacillin

10 (6.3)

37 [10.75–58.25]

Moxifloxacin

9 (5.7)

38 [10–61]

Azithromycin

7 (4.4)

26 [5–58]

Erythromycin

7 (4.4)

47 [3–56]

Rifampin

5 (3.1)

7 [5.5–36]

Amikacin

4 (2.5)

35 [10.75–54]

Ampicillin

4 (2.5)

6 [2–10.75]

Cefepime

4 (2.5)

17.5 [9–55.25]

Tigecycyline

4 (2.5)

30 [7–53.25]

Colistimethate sodium

3 (1.9)

26 [9–29]

Flucloxacillin

2 (1.3)

17–30a

Ofloxacin

2 (1.3)

38-49a

Doxycycline

1 (0.6)

3

Levofloxacin

1 (0.6)

21

  1. aRange